z-logo
open-access-imgOpen Access
Ripretinib
Author(s) -
Silpa S. Kumar,
Arun Philip,
K Pavithran
Publication year - 2021
Publication title -
cancer research statistics and treatment
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_308_20
Subject(s) - pdgfra , medicine , tyrosine kinase inhibitor , gist , tyrosine kinase , receptor tyrosine kinase , imatinib , platelet derived growth factor receptor , gastrointestinal tract , cancer research , stromal cell , imatinib mesylate , targeted therapy , oncology , receptor , growth factor , cancer , myeloid leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom